SynthesisScientific reports2026
Systems-level transcriptomic analysis reveals synapse-related gene dysregulation in peripheral leukocytes of MDD patients.
Synthesis in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Major depressive disorder (MDD) involves both central nervous system dysfunction and systemic immune alterations. Using a systems biology approach, we investigated whether peripheral leukocytes exhibit transcriptional changes in genes annotated to synaptic processes, molecular functions typically associated with neurons but also possibly implicated in immune cell biology. A meta-analysis of transcriptomic data from 3072 individuals identified 1383 meta-differentially expressed genes (metaDEGs) in leukocytes, including 73 whose known functions are linked to synaptic biology. Among them, functional enrichment analysis indicated synapse-related metaDEGs (48 downregulated, 25 upregulated) involved in synaptic vesicle cycling, neurotransmitter signaling, synaptic assembly, and neurogenesis. Linear discriminant analysis (LDA) identified 18 of these genes that robustly distinguished MDD patients from healthy controls across independent datasets. Notably, we identified metaDEGs shared between leukocytes and brain regions associated with MDD, indicating that genes traditionally linked to neuronal pathways are also expressed in immune cells, where they may contribute to immune-related mechanisms relevant to the disorder. These findings highlight potential systemic molecular patterns that warrant further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.